p53 as a hub in cellular redox regulation and therapeutic target in cancer
Open accessThe DOI matches its Crossref record; 130 of the 132 references it cites were found in a registry or an index.
Abstract
The TP53 tumor suppressor gene encodes a DNA-binding transcription factor that regulates multiple cellular processes including cell growth and cell death. The ability of p53 to bind to DNA and activate transcription is tightly regulated by post-translational modifications and is dependent on a reducing cellular environment. Some p53 transcriptional target genes are involved in regulation of the cellular redox homeostasis, e.g. TIGAR and GLS2. A large fraction of human tumors carry TP53 mutations, most commonly missense mutations that lead to single amino acid substitutions in the core domain. Mutant p53 proteins can acquire so called gain-of-function activities and influence the cellular redox balance in various ways, for instance by binding of the Nrf2 transcription factor, a major regulator of cellular redox state. The DNA-binding core domain of p53 has 10 cysteine residues, three of which participate in holding a zinc atom that is critical for p53 structure and function. Several novel compounds that refold and reactivate missense mutant p53 bind to specific p53 cysteine residues. These compounds can also react with other thiols and target components of the cellular redox system, such as glutathione. Dual targeting of mutant p53 and redox homeostasis may allow more efficient treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is established that transcription factor p53 is the master regulator of the DNA damage response and is stabilized and transactivated in response to DNA damage [ 38 , 39 , 40 , 41 ].”
From Differential Induction of Reactive Oxygen Species and Expression of Antioxidant Enzymes in Human Melanocytes Correlate with Melanin Content: Implications on the Response to Solar UV and Melanoma Susceptibility (2022) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
MicroRNA-124 Regulates the Proliferation of Colorectal Cancer Cells by TargetingiASPP
Liu, K., Zhao, H., Yao, H., Lei, S., Lei, Z., Li, T., & Qi, H. (2013) · BioMed Research International · doi:10.1155/2013/867537 · Cited by 60
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695 · cited 16×
“FDXR is a mitochondrial protein involved in iron–sulfur cluster formation and the transfer of electrons from NADPH to cytochrome P450 enzymes.”
BackgroundInfluentialFree radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680 · cited 1×
“Counteracting oxidative stress in order to maintain a reduced environment is essential as accumulation of oxygen species is harmful to the cell and can initiate cancer (Valko et al., 2006).”
BackgroundMutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · cited 2×
“Thus, their redox balance is already pushed to the limit, and a further increase in oxidant species may therefore tip them over the edge and trigger cell death (Gorrini et al., 2013).”
BackgroundFerroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 11×
“As SLC7A11 controls both cystine/cysteine redox cycling and the availability GSH building blocks, the repression of SLC7A11 renders mutant p53 cells more sensitive to oxidative assaults.”
BackgroundInfluentialBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 1×
“Also, p53 has continued to fascinate and surprise investigators through its involvement in a wide range of diverse cellular processes (Vousden and Prives, 2009), and by the discovery of multiple p53 isoforms with as yet poorly understood functions (Marcel et al.”
BackgroundWendel, A. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,009
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 1×
“Thus, as mutant p53 prolongs TNF-α-induced NFκB signaling (Cooks et al., 2013), it is conceivable that mutant p53 can upregulate Nrf2 via NFκB.”
Background
Cited by
Items 101–123 of 123
Ribosome collisions and ZAKα activation: explores the therapeutic potential of metabolic diseases
Zhang, W., Zhang, K., Kan, C., Sheng, S., Hou, N., Han, F., Zhang, J., & Sun, X. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00334.2025 · Cited by 2
ROS and the cell cycle: Cycling in and out of the comfort zone of redox control
Hsiu, O. O. N., & Poon, R. Y. C. (2026) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2026.102613 · Cited by 2
Molina-Vila, M. A., Tsourti, Z., Vervita, K., Bertrán-Alamillo, J., García‐Peláez, B., Kerr, K. M., Bubendorf, L., Madsen, L. B., Biernat, W., Stenzinger, A., et al. (2026) · European Journal of Cancer · doi:10.1016/j.ejca.2026.116583 · Cited by 5
Redox signaling in development: An emerging frontier
Ulfig, A., & Jakob, U. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.07.005 · Cited by 2
Zhang, H., Zhou, J., Dong, L., Zhu, L., & Ye, Y. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-236 · Cited by 5
“…marked and consistent decreases across all treatment conditions ( Figure 4 ). p53 , functioning as a central hub in cellular redox regulation, emerges as a therapeutic target in the realm of cancer (49). p53 governs cellular energy metabolism and orchestrates antioxidant defense mechanisms.”
BackgroundP53, ROS: Redox Regulation Signaling, Metabolic Reprogramming, and Autophagy in Cancer
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_7 · Cited by 3
Myonuclear apoptosis underlies diaphragm atrophy in mechanically ventilated ICU patientsPreprint
Claassen, W. J., van den Berg, M., Shi, Z., Baelde, R., Bogaards, S. J. P., Bonis, L., Hakkeling, H., Bamyani, A., Schaaf, G., Beishuizen, A., et al. (2024) · medRxiv · doi:10.1101/2024.07.23.24310792 · Cited by 1
Redox signaling in regenerative medicine: Regulatory mechanisms and therapeutic implications
Sharifi, A. M., Sharifi, M. A., & Kamarul, T. (2024) · Advances in biogerontology · doi:10.1016/bs.abger.2024.05.001 · Cited by 1
Turan, B. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_24 · Cited by 1
BLVRA promotes glioblastoma progression by regulating fatty acid metabolism
Li, L., Yao, J.-H., Feng, J. H., Qi, Z., Zhan, M.-S., San, H.-B., & Wang, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-19026-2 · Cited by 2
“Excessive ROS can also induce apoptosis through multiple pathways 37 . wild type p53 activation in response to ROS stress leads to cell cycle arrest or apoptosis, whereas mutant p53 upregulates Nrf2, enhancing ROS detoxification as a survival mechanism 38 .”
Making sense of subcellular H2O2 in mammals
Waldeck‐Weiermair, M., Covington, T. A., Pandey, A. K., & Michel, T. M. (2026) · Redox Biochemistry and Chemistry · doi:10.1016/j.rbc.2026.100080 · Cited by 1
He, Y., Cao, N., Tian, Y., Wang, X., Xiao, Q., Tang, X., Huang, J., Zhu, T., Hu, C., Zhang, Y., et al. (2023) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2023453 · Cited by 1
Shirvani, H., Bazgir, B., Rahimi, M., Isanejad, A., Samadi, M., Sobhani, V., Alizadeh, A. M., & Arabzadeh, E. (2021) · Research Square · doi:10.21203/rs.3.rs-151527/v1 · Cited by 1
“P53 is one of the most important inhibitors of cancer, and it has been suggested that the reduction of this gene is effective in the further development of cancers[18].”
Backgroundp53: updates on mechanisms, biology and therapy (II)
Lane, D. P., & Verma, C. S. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz018 · Cited by 1
Redox regulation of the tumor suppressor p53
Shi, T. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/966 · Cited by 1
Correlation of P53 expression and epithelial-mesenchymal transition in non-small cell lung cancer
Wu, X., & Duan, L. (2025) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_277_24 · Cited by 1
Hussein, M. A., Moneim, R. M. A., Hamdy, A. E., Fawzy, E. A., Ismail, A. M., Mohamed, E. A., & El-Adl, N. I. (2025) · Current Bioactive Compounds · doi:10.2174/0115734072395076250916134045
Athineos, D., Wittke, C. I., Morrison, V., Vousden, K. H., Clements, N., Humpton, T. J., Butler, L., Hughes, M., Watt, D. M., & Cheung, E. C. (2025) · OSF Preprints (OSF Preprints) · doi:10.17605/osf.io/7p4t2
Loss of Myonuclei and Transcriptional Activity During Diaphragm Atrophy in Critically Ill Patients
Claassen, W. J., van den Berg, M., Shi, Z. H., Baelde, R., Bogaards, S. J. P., Bonis, L., Hakkeling, H., Bamyani, A., Schaaf, G., Beishuizen, A., et al. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70228
“Because p53 is subject to redox regulation, a redox imbalance may activate the pathway [27].”
Alçiçek, Ş., Manzhurtsev, A. V., Thomas, D. C., Divé, I., Weber, K. J., Prinz, V., Jussen, D., Deelchand, D. K., Oeltzschner, G., Ronellenfitsch, M. W., et al. (2026) · Cancer & Metabolism · doi:10.1186/s40170-026-00432-7
Reactive Oxygen Species and Cell Signaling Pathways
Averill‐Bates, D. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-21135-4_10 · Cited by 1
Horiuchi, Y., Noguchi, H., Taniguchi, A. Y., & Kazami, M. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154209
Abuzaid, H., Abdelrazig, S., Abuawad, A., Hamadneh, L., Turyanska, L., Kim, D., & Bradshaw, T. D. (2026) · The Analyst · doi:10.1039/d6an00497k
Metadata
- Authors
- Eriksson, S. E., Ceder, S., Bykov, V. J. N., & Wiman, K. G.
- Affiliations
- Karolinska Institutet (SE)
- Corresponding author
- Wiman, Klas G
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-02-14
- Volume
- 11
- Issue
- 4
- Pages
- 330-341
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- PMC
- PMC6734141
- OpenAlex
- W2911745809
- Cited by
- 123
- References
- 132
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 19 · 2023: 18 · 2022: 15 · 2021: 20 · 2020: 13 · 2019: 8
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Molecular Cell Biology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Swedish Medical Research Council
- Swedish Cancer Fund
- Swedish Childhood Cancer Fund
- Radiumhemmets Forskningsfonder
- Knut & Alice Wallenberg Foundation
- European Research Council
- Aprea Therapeutics AB
- Karolinska Institutet
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- TP53, p53, cellular redox homeostasis, TP53 mutation, missense mutations, Nrf2, TIGAR, GLS2, zinc binding, glutathione, cancer therapy, transcriptional regulation
- MeSH terms
- Antioxidants, DNA, Humans, Neoplasms, Sulfhydryl Compounds, Tumor Suppressor Protein p53, Oxidative Stress, Mutation, Missense, Small Molecule Libraries, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.